Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043013
Filing Date
2019-11-12
Accepted
2019-11-12 17:03:55
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20190930.htm 10-Q 2157680
2 EX-3.1 ttph-ex31_267.htm EX-3.1 385780
3 EX-31.1 ttph-ex311_8.htm EX-31.1 17284
4 EX-31.2 ttph-ex312_7.htm EX-31.2 17541
5 EX-32.1 ttph-ex321_10.htm EX-32.1 6207
6 EX-32.2 ttph-ex322_13.htm EX-32.2 6499
  Complete submission text file 0001564590-19-043013.txt   7163508

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ttph-20190930.xml EX-101.INS 1208665
8 XBRL TAXONOMY EXTENSION SCHEMA ttph-20190930.xsd EX-101.SCH 59130
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20190930_cal.xml EX-101.CAL 43514
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20190930_def.xml EX-101.DEF 175729
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20190930_lab.xml EX-101.LAB 455248
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20190930_pre.xml EX-101.PRE 326938
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 191210624
SIC: 2834 Pharmaceutical Preparations